openPR Logo

Press Releases from PNS Pharma (112 total)

Global Cancer Vaccine Market & Clinical Trial Insight 2025

Recent published report “Global Cancer Vaccine Market & Clinical Trial Insight 2025“ by PNS Pharma highlights on going developments in the field of cancer vaccine market research and clinical trials. currently there are more than 15 cancer vaccines commercially available in the market and close to 370 are in clinical Trial or pipeline. Most of the vaccines in development phases are for the treatment of Breast cancer and

Global Orphan Drug Pipeline & Regulatory Insight 2025

” Global Orphan Drug Pipeline & Regulatory Insight 2025” Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Report TOC Orphan Drugs: Regimens For Rare Diseases Drivers of Orphan Drug Commercialization 2.1 Cost

Global Orphan Drug Pipeline & Regulatory Insight 2025

” Global Orphan Drug Pipeline & Regulatory Insight 2025″ Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Orphan Drugs: Regimens For Rare Diseases Drivers of Orphan Drug Commercialization 2.1 Cost

Global Cancer Vaccine Market & Clinical Trial Insight 2025

Global Cancer Vaccine Market & Clinical Trial Insight 2025″ Report Highlight: Global Cancer Vaccine Market Opportunity: US$ 15 Billion Opportunity Personalized Cancer Vaccine: The Next growth Frontier Global Cancer Vaccine Clinical insight by Indication & Phase of Development Global Cancer Vaccine Pipeline: 369 Cancer Vaccines Marketed Cancer Vaccines: 17 Cancer Vaccines Maximum Vaccines in Pipeline for Brain & Breast Cancer: 43 Cancer Vaccines Regulatory Landscape Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Cancer-Vaccine-Market-%26-Clinical-Trial-Insight-2025 Introduction to Cancer Vaccines Mechanism

Global Orphan Drug Market Offers USD 250 Billion Opportunity By 2025

Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Total sales of orphan designated drugs is expected to surpass US$ 250 Billion by 2025 as per recent report “Global Orphan Drug Pipeline & Regulatory Insight 2025” published by PNS Pharma. The strong clinical pipeline and availability of more than 350 orphan designated drugs in the market will drive the global orphan drug market in coming years. "Global Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights: • Global Orphan Drug

Global Cancer Vaccine Market Opportunity Valued At USD 15 Billion

Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Cancer-Vaccine-Market-%26-Clinical-Trial-Insight-2025 "Global Cancer Vaccine Market & Clinical Trial Insight 2025” Report Highlight: • Global Cancer Vaccine market Opportunity: US$ 15 Billion opportunity • Personalized Cancer Vaccine: The Next growth Frontier • Global Cancer Vaccine Clinical insight by Indication & Phase of Development • Global Cancer Vaccine Pipeline: 369 Cancer Vaccines • Marketed Cancer Vaccines: 17 Cancer Vaccines • Maximum Vaccines in Pipeline for Brain & Breast Cancer: 43 Cancer Vaccines • Regulatory Landscape The cancer vaccine market is expected to reach USD 15 Billion

Orphan Drug Pipeline & Regulatory Insight 2025

Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights: Global Orphan Drug Market Overview: US$ 260 Billion Opportunity Global Orphan Drug market by Segment Regulatory Landscape: USA, Europe & Asia Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia Global Orphan Drug Clinical Pipeline Insight: 973 Drugs Marketed Orphan Drug Clinical Insight: 366 Drugs The global orphan drug market opportunity is expected to surpass US$ 260 Billion by 2025 as per

Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024

" Global Cancer Monoclonal Antibodies Market &Clinical Trial Insight 2024" Report Highlights: * Significance for Monoclonal Antibodies for Cancer Treatment * Global Cancer Monoclonal Antibodies Market Overview * Global Cancer Monoclonal Antibodies Pipeline by Phase & Indication * Global Cancer Monoclonal Antibodies Pipeline: 697 mAb * Marketed Cancer Monoclonal Antibodies: 60 * Global Cancer Monoclonal Antibodies Market Opportunity: US$ 140 Billion The recent years have witnessed the emergence of monoclonal antibodies, which has the potential

Global Orphan Drug Pipeline & Regulatory Insight 2025

" Global Orphan Drug Pipeline & Regulatory Insight 2025" Report Highlights: * Global Orphan Drug Market Overview: US$ 260 Billion Opportunity * Global Orphan Drug market by Segment * Regulatory Landscape: USA, Europe & Asia * Orphan Drug Designation & Reimbursement Policy: USA, Europe & Asia * Global Orphan Drug Clinical Pipeline Insight: 973 Drugs * Marketed Orphan Drug Clinical Insight: 366 Drugs Download Report: http://www.pnspharma.com/buy-report.php?reporttitle=Global-Orphan-Drug-Pipeline-%26-Regulatory-Insight-2025 Contact For Report Sample: rajesj@pnspharma.com The global orphan drug market

Global Peptide Drug Market To Surpass USD 50 Billion by 2024

Global peptide drug market is expected to surpass US$ 50 billion by 2024 as per recent report published by PNS Pharma. Currently there are more than 600 peptide drug in clinical pipeline and more than 100 are commercially available in the market. “Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024” Report Highlight: * Global Peptide Therapeutics Market Opportunity: More Than US$ 50 Billion * Cost Analysis & Market Insight into

Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024 …

“Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024” Report Highlight: * Global Peptide Therapeutics Market Opportunity: More Than US$ 50 Billion * Cost Analysis & Market Insight into its Application * Dosage & Sales Analysis of Key Drugs * Global Peptide Drug Clinical Pipeline: 612 Drugs * Peptide Drug Application by Indication * Global Peptide Pipeline by Indication, Company & Phase * Marketed Peptide Drugs: 101 Drugs * Clinical Trials Insight by Peptide Classification Download

Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024

“Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024” Report Highlight: * Global Peptide Therapeutics Market Opportunity: More Than US$ 50 Billion * Cost Analysis & Market Insight into its Application * Dosage & Sales Analysis of Key Drugs * Global Peptide Drug Clinical Pipeline: 612 Drugs * Peptide Drug Application by Indication * Global Peptide Pipeline by Indication, Company & Phase * Marketed Peptide Drugs: 101 Drugs * Clinical Trials Insight by Peptide

Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024

“Global Peptide Therapeutics Market, Dosage, Price & Clinical Trials Insight 2024” Report Highlight: * Global Peptide Therapeutics Market Opportunity: More Than US$ 50 Billion * Cost Analysis & Market Insight into its Application * Dosage & Sales Analysis of Key Drugs * Global Peptide Drug Clinical Pipeline: 612 Drugs * Peptide Drug Application by Indication * Global Peptide Pipeline by Indication, Company & Phase * Marketed Peptide Drugs: 101 Drugs * Clinical Trials Insight by Peptide

Global Cancer Peptide Drug Market To Surpass USD 16 Billion By 2024

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Fundamentals of Peptide Therapeutics * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook Download Report Sample Weblink: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market-%26-Clinical-Trials-Insight-2022 For Report Sample Contact: rajesh@pnspharma.com Table of Contents 1. A Revolution of Peptide Therapeutics

Global Cancer Peptide Drug Market To Surpass USD 16 Billion By 2024

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Fundamentals of Peptide Therapeutics * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook Download Report Sample Weblink: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market-%26-Clinical-Trials-Insight-2022 For Report Sample Contact: rajesh@pnspharma.com Table of Contents 1. A Revolution of Peptide Therapeutics

Global Peptide Drug Market To Surpass USD 45 Billion By 2024

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Fundamentals of Peptide Therapeutics * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook Download Report Sample Weblink: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market-%26-Clinical-Trials-Insight-2022 For Report Sample Contact: rajesh@pnspharma.com Table of Contents 1. A Revolution of Peptide Therapeutics

Global Peptide Therapeutics Market & Clinical Trials Insight 2022

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook Download Report Sample Weblink: http://pnspharma.com/buy-report.php?reporttitle=Global-Peptide-Therapeutics-Market-%26-Clinical-Trials-Insight-2022 For Report Sample Contact: neeraj@kuickresearch.com Table of Contents 1. A Revolution of Peptide Therapeutics 1.1 Peptides as Drug

Global Peptide Drug Market To Surpass USD 35 Billion by 2022

“Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report highlight * Fundamentals of Peptide Therapeutics * Peptide Therapeutics by Applications & Indications * Peptides Clinical Trials Insight by Phase, Indication & Company * Insight on 688 Peptide Drugs in Clinical Trials * Clinical & Patent Insight on 119 Marketed Peptides * Future Peptide Therapeutics Market Outlook “Global Peptide Therapeutics Market & Clinical Trials Insight 2022” report gives comprehensive insight into the various clinical and non-clinical issues

Europe Breast Cancer Drug Pipeline Analysis

The pharmaceutical companies have recently been focusing increasingly on women's health. Among the diseases specific to women, breast cancer has become one of the leading causes of death for the women population globally and accounts for almost 3 per cent of the causes of death in women. It has been estimated that one in every 12 women is most likely to develop breast cancer at some point in her life,

US Breast Cancer Drug Pipeline Analysis

The pharmaceutical companies have recently been focusing increasingly on women's health. Among the diseases specific to women, breast cancer has become one of the leading causes of death for the women population globally and accounts for almost 3 per cent of the causes of death in women. It has been estimated that one in every 12 women is most likely to develop breast cancer at some point in her life,

US Prostate Cancer Drug Pipeline Analysis

Prostate cancer has emerged as one of the most commonly diagnosed cancer among men in the US. According to the American Cancer Society, there were close to 242,000 new cases of prostate cancer in the US in 2012, with 28,000 men dying from it. This was an increase from 206,640 men diagnosed with the condition during 2009. The number of men being actively treated for prostrate disorders such as benign

US Alzheimer Drug Pipeline Analysis

In US, the Alzheimer's disease is the 6th leading cause of death overall and among those aged 65 and above, it is the 5th leading cause of death. While the deaths from major diseases, like heart disease have decreased, the death due to Alzheimer's have increased by more than 60% between 2000 and 2012. The total number of patients having Alzheimer’s disease was 5.4 million in 2012. Out of this,

Orphan Drugs for Cancer Pipeline Analysis

A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed

Global HIV Infection Pipeline Analysis

The discovery of HIV virus, which causes AIDS, dates back to more than 30 years. Currently, there are more than 30 drugs in the market which have been approved by the FDA for the treatment of HIV infection. Consequent to the introduction of retrovirals in 1996, HIV is not considered to be a death sentence anymore. The advancements in this field have led to new drugs being produced which have

Global Infertility Drug Pipeline Analysis

The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to scale up in order to meet the needs of infertile couples and also due to growth in reproductive tourism. Venture capitalists have entered the market by investing

US Orphan Drug Pipeline Analysis

In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the pharmaceuticals industry.

Global Oncolytic Virus Therapy Pipeline Analysis

Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients. Immunotherapy, the umbrella for Oncolytic viruses would not offer cures, but survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the most important approach to treat

Global DNA Vaccine Pipeline Analysis

he global market for DNA vaccines is currently recording significant growth rates owing to the lesser side effects, ease of development, lesser cost and continued development in biotechnology arena. At present, not even a single DNA vaccine has been approved for human beings. However, around 100 products are under clinical trial for treating diseases like HIV infection, cancer and other infectious diseases. With regards to animal health, there are three

Global RNAi Drug Pipeline Analysis

“Global RNAi Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. Research report covers all the ongoing drugs being developed in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in

Global Cancer Vaccines Pipeline Analysis

Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Therapeutic cancer vaccines and Prophylactic cancer vaccines are the two broad segments into which the cancer vaccines market is categorized. North America has the largest share

Global Cell Therapy Pipeline Analysis

“Global Cell Therapy Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Cell Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight

Gene Therapy Drug Pipeline Analysis

“Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight

Pancreatic Cancer Drug Pipeline Analysis

“Pancreatic Cancer Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Pancreatic Cancer. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each

Hepatitis C Drug Pipeline Analysis

“Hepatitis C Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Hepatitis C. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each

Malaria Disease Drug Pipeline Analysis

“Malaria Disease Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles being developed for the treatment of Malaria. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. Insight for each drug

Europe Orphan Drugs Pipeline Analysis

“Europe Orphan Drugs Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drug profiles under Orphan Drugs status in Europe. Research report covers all the ongoing drug development in various phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Chemical Formula, Country of Development and detailed analysis on the development process. The information for particular drug

US Parkinson’s Disease Drug Pipeline Analysis

Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds

US Colorectal Cancer Drug Pipeline Analysis

Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die

US Lung Cancer Drug Pipeline Analysis

The most common type of cancer in terms of incidence and mortality rate is Lung cancer. Lung cancer is a disease in which the lining of the cell of the lung tissue has an uncontrollable growth which in turn leads to the formation of tumor. There are two main types of lung cancer; small cell lung cancer which accounts for about 20% and non-small cell lung cancer (NSCLC) that accounts

US Cancer Vaccine Pipeline Analysis

Cancer vaccines are a viable option for treating many types of cancers which in the present day do not have effective treatments. With the approval of the expensive prostate cancer vaccine, Provenge by Dendreon, the field of cancer vaccines has received an unprecedented boost. Consequently, many companies are expected to enter this emerging and highly profitable field of preventing, treating, and potentially curing cancer. Merck’s Gardasil, a Prophylactic cancer vaccine,

Global Monoclonal Antibodies Pipeline Analysis

The market for monoclonal antibodies (mAB) has become the fastest growing segment of the pharmaceutical industry. In 2012, there were more than 30 monoclonal antibody therapies approved by the FDA which generated annual sales of more than US$ 40 Billion. As the therapeutic mABs already play a significant part in effective medical treatment, it is most likely that their importance would increase by manyfolds in the future. There has been a

Global Orphan Drug Pipeline Analysis

In recent years, the pharmaceutical industry has been experiencing a paradigm shift. While a large pool of patients was considered as a major source of revenue for pharma companies in the past, the focus is now gradually shifting to small sections of patients suffering from rare disease. In US & Europe, this pool of patients is gradually growing and orphan drugs are becoming an extremely attractive business proposition for the

Global Cancer Monoclonal Antibodies Pipeline Analysis

In the past few years monoclonal antibodies have emerged as a therapeutic modality for cancer. These monoclonal antibodies are designed to selectively target cancer cells and extract various responses, thus indirectly protecting the non cancerous cells. This characteristic of monoclonal antibodies coupled with increasing potential of the oncology market has made many pharmaceutical giants to invest a significant portion of their R&D on cancer monoclonal antibodies. In recent years the popularity

Europe Parkinson’s Disease Drug Pipeline Analysis

Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that

Europe Alzheimer’s Drug Pipeline Analysis

The incidence of Alzheimer’s disease has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been observed that close to 50% of dependency of aged people in Europe is attributed for by Alzheimer’s disease. The rapid growth in the prevalence of Alzheimer's disease over the next few decades in Europe is expected to result in immense pressure

Japan Cancer Drug Pipeline Analysis

Japan is a significant market for cancer and its related drugs in the Asia-Pacific region. Improved access to healthcare and an increased level of awareness about cancer and the options for its treatment have been major drivers for a rise in the research activities in this country. With the strong continued support from the government, the Japanese cancer market is expected to grow rapidly in the future years. The government has

Schizophrenia Drug Market & Pipeline Insight

Schizophrenia is defined as a disorder of the brain which impacts the way in which a person acts, thinks, and sees the world. It has been observed that the patients suffering from schizophrenia generally tend to have an altered perception of reality, which reveals a significant diversion from the reality. In most cases, schizophrenia is diagnosed among people in the late teens or early adulthood. However, middle-aged people also could

Cancer Cytokines Therapy Pipeline Analysis

Cytokines, a major group in the protein therapeutics umbrella, are known to be soluble extracellular proteins or glycoproteins which are crucial intercellular regulators, having the capacity to mobilize the cells which are engaged in innate as well as adaptive inflammatory host defenses, cell growth, differentiation, cell death, angiogenesis, and development and repair processes aimed at the restoration of homeostasis. These proteins are being used mostly for cancer patients due to

Human Papillomavirus Infections Vaccine Pipeline Analysis

Currently there is significant amount of research being undertaken to study the process of HPV infection causing precancerous changes in normal cells. Also, methods to prevent and manage this situation are also being analyzed. A majority of these studies were previously focusing on cervical cells in women. But in recent years, the realm of research has been extended to other tissues also in which HPV may cause cancer, such as

Crohn’s Disease Drug Market and Pipeline Analysis

Under the umbrella of inflammatory bowel diseases, Crohn’s disease and ulcerative colitis are two most common disorders. Though both these disorders have similar symptoms, the difference arises in the areas affected in the gastrointestinal tract (GI tract). The Crohn’s disease in most cases affects the end of the small bowel (the ileum) and the beginning of the colon, but it may affect any part of the gastrointestinal (GI) tract, from

Go To Page: 1 3